Navigating Pancreatic Cancer
We are here to empower you to ask bold questions, seek out the best treatment options, and face the unique challenges of pancreatic cancer head-on. We want to give you the resources and information you need to make informed decisions that are best for you.
As overwhelming as a pancreatic cancer diagnosis is, it is important to act quickly and put a treatment plan into place. Treatment should ideally begin within one month after you receive your diagnosis. Understand your disease. Thoroughly understand what stage of pancreatic cancer you have and inquire about having your blood and tumor genetically sequenced. […]
If you have been diagnosed with pancreatic cancer, a clinical trial may be your best treatment option. Many clinical trials are underway for patients in all stages of the disease and may involve new combinations of currently available drugs or new drugs that have worked in other cancers. No matter where you are in your journey, we encourage you to learn more about clinical trials.
LET’S WIN! Pancreatic Cancer A Dynamic Way to Share Information Recognizing that there is an urgent need for patients to communicate amongst themselves and with the medical community about potentially life-changing treatments and clinical trials, we are proud to be affiliated with Let’s Win. Let’s Win is an interactive online community where patients and families […]
Pancreatic Cancer Connections is online social community that provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Patients interact with others who are facing a pancreatic cancer and can post questions to the board or message other members privately. This community forum is a valuable resource for patients, caregivers, and their loved ones to refer to at various stages of their treatment and recovery.
Patients and loved ones can sign up for Pancreatic Cancer Connections at no cost and will be welcomed into an engaging and supportive community to discuss topics including treatment options, nutrition, and coping with the disease. Pancreatic Cancer Connections is hosted by Inspire, a leading healthcare social network that connects more than 1,000,000 patients and caregivers.
New Funding Opportunity
The intent of this program is to support pancreatic cancer research critical to advancing our understanding of pancreatic cancer initiation, progression and the development of new therapies in four areas of focus: Desmoplastic Stroma, Chronic Inflammation, Metabolic Dysregulation,Early Metastasis
Candidates must be nominated by their institution prior to submission (limit one nomination per institution), and submit a 2 page Letter of Intent (LOI) by June 30. The LOI must include a letter of support from the institute director, detailing the rationale for the nomination and qualifications of the investigator. Despite considerable advances in our understanding of pancreatic cancer initiation and progression, development of new therapies and significant changes to treatment and outcomes lag behind. Improved understanding of the biology underlying pancreatic cancer should lead to the identification of new dependencies that are therapeutically tractable.
HOPE From Home
Pancreatic cancer can’t wait—and neither can we.
It’s safe to assume the COVID-19 pandemic has had a dramatic effect on everyone. Almost overnight, we’ve all had to make dramatic transitions to cope with this new reality and to protect ourselves and our communities. Added to that are the very real concerns about the impact COVID-19 will have on those battling pancreatic cancer. We’ve heard from many of you who want to remain engaged with and to help the pancreatic cancer community, so we’ve launched a new opportunity for you to provide the entire Lustgarten family with a little bit of HOPE
“HOPE From Home” is designed to provide you, our valued supporters, a variety of opportunities to support our mission even while social distancing at home. Your participation can help us raise critical funds for pancreatic cancer research and awareness about this dreaded disease. You can show your neighborhood, community and on-line network that pancreatic cancer can’t wait—and neither can we.
Our Response to COVID-19
How Lustgarten is Responding to COVID-19
A letter from the CEO
Hi and thank you for checking in with the Lustgarten Foundation to learn more about our response to the novel coronavirus, or COVID-19.
Seemingly overnight, COVID-19 has dramatically changed the world in which we live. I sincerely hope you and your loved ones are well.
We at the Lustgarten Foundation are doing our best to follow the CDC guidelines, practice social distancing and to help flatten the curve. As of Tuesday, March 17, all staff are working remotely, but we are staying in touch with one another and continue to be here for you. Though images from major cities and small towns across the country almost make it feel that life has stopped, we know the fight against pancreatic cancer cannot wait.
For now, we have postponed or cancelled all events through the end of May—if you were already registered for one of these events, you should have received an email with everything you need to know. If you missed the email or are just now considering registering for an event, we’ve posted all the details below. Of course, if you have questions about pancreatic cancer, fundraising, walks or anything else, please get in touch. Call us tollfree at 866-789-1000 or send an email to email@example.com. We check the messages daily and one of us will get back to you as soon as possible.
To keep up with the latest pancreatic cancer research information and Lustgarten Foundation activities, follow us on Facebook, Instagram, LinkedIn and Twitter.
We know this is a difficult and uncertain time, and we also know we will get through this together. Please follow the recommendations of your healthcare provider and practice social distancing as much as possible (but remember, Skype and FaceTime are great options to keep you connected with friends and family) and stay healthy and safe.
President and CEO
Pancreatic Cancer NewsView All Articles
Cancer cells can turn on error-prone DNA copy pathways to adapt to cancer treatment, a breakthrough study published in the journal Science has revealed. Bacteria use the same process, termed stress-induced mutagenesis, to develop antibiotic resistance. The cells of the human body are constantly dividing, and each time need to copy a three billion-letter DNA […]
The presence of either germline or somatic mutations that encode proteins involved in a form of DNA repair known as homologous recombination (HR) identifies patients with advanced pancreatic cancer who are going to respond best to first-line (1L) platinum therapy, new research shows. From 5% to 9% of patients with pancreatic cancer harbor germline or somatic mutations […]
A team of researchers from the UCLA Jonsson Comprehensive Cancer Center and peer institutions has been awarded a $5.75 million grant from the National Cancer Institute to study the correlation between obesity, inflammation and pancreatic cancer. The scientists hope their findings may help people avoid getting this cancer. “We know that the biological mechanisms of […]
A clinical trial led by researchers from the University of Cincinnati has found that one-third of patients receiving chemotherapy before surgery for pancreatic cancer had very encouraging results at the time of the procedure. The results of this National Cancer Institute’s SWOG Cancer Research Network trial will be presented as part of the ASCO20 Virtual […]
Pancreatic ductal adenocarcinoma (PDA) is a deadly cancer, killing patients within a year. CSHL Professor Christopher Vakoc and his former postdoc Timothy Somerville discovered how pancreatic cells lose their identity, acquire a deadly new identity, and recruit nearby cells to help them grow, promote inflammation, and invade nearby tissues. This understanding could lead to new therapies […]
— Risk-prediction model uses biomarkers added to clinical and genetic risk factors A risk-prediction model combining genetic and clinical factors with circulating biomarkers can identify people at notably higher than normal risk of pancreatic cancer who could benefit from screening and early detection, a U.S. nested case-control analysis suggested. The study’s final integration of three […]
Like every other aspect of life at this time, pancreatic cancer treatment and research has been altered by the COVID-19 pandemic. The very same scientists that work to develop better treatments and earlier detection are faced with new obstacles. This very contagious virus is affecting clinical trials and research in a number of ways. COVID-19 […]
blood test may be able to detect the most common form of pancreatic cancer while it is still in its early stages while also helping doctors accurately stage a patient’s disease and guide them to the appropriate treatment. A multidisciplinary study found the test—known as a liquid biopsy—was more accurate at detecting disease in a […]
Pancreatic cancer is expected to become the second-deadliest cancer in the United States by 2030. Many researchers believe that the rise in obesity is a key factor in this increase. A new study led by Yale Cancer Center (YCC) researchers has demonstrated in mice that hormones released from the pancreas itself can advance the cancer—and […]
Scientists at Sanford Burnham Prebys have found a new way to kill pancreatic cancer cells by disrupting their pH equilibrium. The study, published in Cancer Discovery, reports how depleting an ion transport protein lowers the pH to a point that compromises pancreatic cancer cell growth. Pancreatic cancer cells–like all cancer cells–have a constant need for energy to support […]